| |
|
|
|
Immune Pharmaceuticals Inc  
|
|
0.341 0.006 (0.02%) |
04-20 15:58 |
|
Open: |
0.331 |
Pre close: |
0.3347 |
Target:
|
0.42
|
|
High: |
0.3497 |
Low: |
0.331 |
Resistance:
|
0.36
0.40
|
|
Volume: |
161,543 |
Market Cap: |
11M |
Support:
|
0.30
0.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.34
 |
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
0.34 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.52 |
Stochastic Oscillator |
%K(14,3):
|
41.11 |
|
MA(250): |
1.33 |
%D(3): |
42.72 |
|
Average Volume(K) |
3-Month: |
108141
|
52-Week |
High:
|
3.43 |
|
10-Days: |
21344 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
44.17 |
Change(%): |
-87.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-304.3 |
Shares Out. (M) |
31.90 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-103.8 |
Shares Float (M) |
23.76 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
27.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.90 |
|
Forward EPS |
-1.541 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1113 |
|
Book Value (p.s.) |
0.860 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.40 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.14 |
P/CF |
-0.94 |
|
|
|
|
|
|
